57:41
Newomics Webinar in collaboration with University of Wisconsin-Madison
55:28
Newomics - Regeneron Webinar
00:53
Newomics platform for LC-MS = MnESI ion source + M3 emitter
02:11
MnESI Ion Source Unboxing
01:49
MnESI Installation
03:15
M3 Emitter Alignment
01:52
M3 Emitter Cleaning & Removal
01:10:51
Thermo Fisher Scientific - Newomics Joint Webinar
01:56
Newomics - Enabling Precision Medicine
45:09
A New LC-MS Platform for Antibody Analysis - Native MS
11:21
Newomics Bruker eXceed Symposia ASMS 2021
34:32
Webinar Newomics - Cedars Sinai: A sensitive solution for microflow LC-MS analysis of plasma samples
03:07
Newomics Inc. M3 Emitter
X
About
Enabling Precision Medicine
Newomics Inc., an early-stage biotechnology company in the San Francisco Bay Area, commercializes innovative (New) and integrative (Omics) platforms and solutions for personalized healthcare.
Our proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS) and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine.
Tags